I agree that CRs dilute ones holding in the company if not taken up but on the flip side the company should be using the funds to add to the asset base of the company along the way. This is as true for biotechs like AHZ as it is for the mining companies in the exploration phase.
- Forums
- ASX - By Stock
- AVR
- hsv2 final results
hsv2 final results, page-77
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$14.64 |
Change
-0.360(2.40%) |
Mkt cap ! $311.5M |
Open | High | Low | Value | Volume |
$15.00 | $15.00 | $14.50 | $33.87K | 2.304K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 115 | $14.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.64 | 216 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 115 | 14.360 |
1 | 60 | 14.350 |
1 | 200 | 14.300 |
1 | 38 | 14.260 |
1 | 200 | 14.200 |
Price($) | Vol. | No. |
---|---|---|
14.640 | 261 | 2 |
14.670 | 345 | 1 |
14.680 | 60 | 1 |
14.730 | 27 | 1 |
14.850 | 47 | 1 |
Last trade - 11.33am 15/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online